Viracta Therapeutics, Inc.

Viracta is a precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide. Their team possesses deep, cross-functional experience and shares a longstanding commitment to developing new medicines to benefit cancer patients. They are a precision oncology company focused on the treatment and prevention of virus-associated cancers…More that impact patients worldwide. Their lead product candidate is Nana-val, an all-oral combination therapy of their proprietary investigational drug, nanatinostat, and the antiviral agent valganciclovir.